Type 2 Diabetes
PhytoMedical enters into expanded collaborative agreement for type 2 diabetes compound
Published in Obesity and Diabetes Week, April 17th, 2006
PhytoMedical Technologies, Inc. (PYTO, ET6) announced that it recently has extended the term and scope of its three-way Cooperative Research and Development Agreement (CRADA) with Iowa State University (ISU) and the U.S. Department of Agriculture's (USDA) Agricultural Research Service (ARS) so as to allow the company to accelerate its research plans for the development of a new compound for the treatment of type 2 diabetes.
"Our expanded CRADA is an important step in accelerating the level of our research activities and reflects the confidence that we have in the potential of our science and our scientific team," states Harmel S. Rayat, president and CEO of PhytoMedical...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes Control
Moderate exercise improved whole-day glycemic control in obese with type 2 diabetes - Diet & Nutrition
Chronic high-fat and high-sucrose diets differentially affect glucose intolerance in mice - Metabolic Syndrome Risk Factors
Small dense ow-density lipoprotein might be a risk factor for metabolic syndrome development - Obesity Pathogenesis
Adipocyte fatty acid-binding protein is obesity and metabolic syndrome-related biomarker - Obesity Pathogenesis
Hepatic leptin resistance due to PTP1B overexpression may lead to diabetes and obesity - Angiology
Mesenteric fat thickness is linked to metabolic syndrome and cardiovascular disease risk - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
